GGrantIndex
← Leaderboards

Gregory B Carey

American National Red Cross

$3,115,228
Attributed
$4,578,417
Total exposure
5
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $361.4K · FY200525
$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$4,578,417 · 5

By mechanism

R25$2,643,057 · 1
K01$692,490 · 1
K22$602,200 · 1
UH2$354,967 · 1
T35$285,703 · 1

Top collaborators

Most similar at American National Red Cross

Same institution · by research overlap

Others in their field

Top investigators on “United States

Research focus

United StatesApoptosisDesignEnvironmentInnovationLeadMentorsEnsureResearch TrainingCareerFacultyProgramsStudentsEvaluationLearningEnrollmentBiomedical ResearchLifeDoctor Of PhilosophyFundingEducational WorkshopDevelopment PlansInstitutionBaltimore

Grant awards (23)

UMB Postbaccalaureate Research Education Program$357,844
R25 · FY2025 · GM · contact PI
UMB Postbaccalaureate Research Education Program$357,844
R25 · FY2024 · GM · contact PI
UMB Postbaccalaureate Research Education Program$357,844
R25 · FY2023 · GM · contact PI
UMB Postbaccalaureate Research Education Program$358,161
R25 · FY2022 · GM · contact PI
UMB Postbaccalaureate Research Education Program$361,401
R25 · FY2021 · GM · contact PI
UMB Postbaccalaureate Research Education Program$283,321
R25 · FY2020 · GM · contact PI
UMB Postbaccalaureate Research Education Program$283,321
R25 · FY2019 · GM · contact PI
UMB Postbaccalaureate Research Education Program$283,321
R25 · FY2018 · GM · contact PI
Short-term Training Program on Aging$144,050
T35 · FY2014 · AG · contact PI
Short-term Training Program on Aging$141,653
T35 · FY2013 · AG · contact PI
Role of Reactive Oxygen Species in B Lymphoma Fate$100,159
UH2 · FY2012 · CA · contact PI
Role of Reactive Oxygen Species in B Lymphoma Fate$254,808
UH2 · FY2011 · CA · contact PI
Selective Targeting of MEK and AKt in Lymphoma and Myeloma Apoptosis$167,400
K22 · FY2009 · CA · contact PI
Selective Targeting of MEK and AKt in Lymphoma and Myeloma Apoptosis$100,000
K22 · FY2009 · CA · contact PI
Selective Targeting of MEK and AKt in Lymphoma and Myeloma Apoptosis$167,400
K22 · FY2008 · CA · contact PI
Selective Targeting of MEK and AKt in Lymphoma and Myeloma Apoptosis$167,400
K22 · FY2007 · CA · contact PI
mIgM and mIgD Receptor Signaling in B Lymphoma Apoptosis$161,730
K01 · FY2006 · CA · contact PI
mIgM and mIgD Receptor Signaling in B Lymphoma Apoptosis$161,730
K01 · FY2005 · CA
mIgM and mIgD Receptor Signaling in B Lymphoma Apoptosis$117,445
K01 · FY2004 · CA
mIgM and mIgD Receptor Signaling in B Lymphoma Apoptosis$25,331
K01 · FY2004 · CA
mIgM and mIgD Receptor Signaling in B Lymphoma Apoptosis$13,885
K01 · FY2004 · CA
mIgM and mIgD Receptor Signaling in B Lymphoma Apoptosis$107,478
K01 · FY2003 · CA
mIgM and mIgD Receptor Signaling in B Lymphoma Apoptosis$104,891
K01 · FY2002 · CA